Drug utilisation pattern among neonates admitted to a tertiary care neonatal intensive care unit: a prospective observational study

Yash Patel; Vimesh R. Mistry; Neeta Kanani; Kuntal Jain; Keval Patel

doi:10.18203/2319-2003.ijbcp20263770

Authors

Yash Patel Department of Pharmacology, Medical College Baroda, Vadodara, Gujarat, India
Vimesh R. Mistry Department of Pharmacology, Medical College Baroda, Vadodara, Gujarat, India
Neeta Kanani Department of Pharmacology, Medical College Baroda, Vadodara, Gujarat, India
Kuntal Jain Department of Pharmacology, Medical College Baroda, Vadodara, Gujarat, India
Keval Patel Department of Pharmacology, Medical College Baroda, Vadodara, Gujarat, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20263770

Keywords:

Drug utilisation study, Neonates, Neonatal intensive care unit, WHO prescribing indicators, Prescription pattern, Antibiotic utilisation

Abstract

Background: Neonates in NICUs frequently require numerous medications because of severe illnesses and immature physiology. Drug utilization studies help identify prescribing trends and potential areas for enhancing rational pharmacotherapy. This research assessed drug utilization patterns among neonates in a tertiary care NICU, utilising World Health Organization (WHO) prescribing indicators.

Methods: A prospective study over eight months (May–December 2025) was conducted in a NICU at a tertiary hospital in Gujarat, India. Neonates receiving at least one therapeutic medication and meeting eligibility criteria were enrolled. Demographic, clinical data, prescribed medications, therapeutic classes, and antibiotic use were recorded. Prescribing practices were assessed using WHO indicators, and drugs classified via the WHO ATC system.

Results: A total of 302 neonates received 1581 prescribed medications, with an average of 5.23±2.93 drugs per encounter. Generic drugs made up 67.17%, and 79.32% of the medications were from the National List of Essential Medicines 2022. Antibiotics were prescribed in 85.10% of cases, and injections in all cases. Antibiotics represented the largest therapeutic category at 49.40%. The most frequently prescribed drugs were calcium gluconate (81.13%), piperacillin–tazobactam (73.51%), and gentamicin (66.89%). No significant differences were found between preterm and full-term neonates regarding the average number of medications, antibiotic use, or length of hospital stay.

Conclusions: The prescribing pattern reflected the clinical complexity of neonates requiring intensive care, with substantial use of antibiotics and supportive medications. Regular drug utilisation monitoring and antimicrobial stewardship may help promote rational and safe pharmacotherapy in NICUs.

References

Allegaert K, van den Anker JN. Clinical pharmacology in neonates: small size, huge variability. Neonatology. 2014;105(4):344-9.

Kshirsagar VD, Rajderkar SS. An assessment of admission pattern and treatment outcomes of neonates admitted in centers under facility-based newborn care program in Maharashtra, India. J Family Med Prim Care. 2022;11(7):3455-8.

Allegaert K. Rational use of medicines in neonates: current observations, areas for research and perspectives. Healthcare (Basel). 2018;6(3):115.

World Health Organization. Introduction to drug utilization research. Geneva: World Health Organization; 2003. Available from: https://www.who.int/publications/i/item/82808203964 Accessed on 10 July 2026.

Krishnamurthy S, Ramakrishna BK, Rajendiran R, Kumar T, Fairlin P, Dhanabalan O. Analysis of antimicrobial utilization pattern in neonatal intensive care unit: a prospective observational study. J Pharm Bioallied Sci. 2026;18(1):46-9.

Choonara I. Evaluation of rational prescribing in paediatrics. BMJ Paediatr Open. 2021;5(1):e001045.

Gujar A, Gulecha DV, Zalte DA. Drug utilization studies using WHO prescribing indicators from India: a systematic review. Health Policy Technol. 2021;10(3):100547.

Al-Turkait A, Szatkowski L, Choonara I, Ojha S. Review of drug utilization studies in neonatal units: a global perspective. Int J Environ Res Public Health. 2020;17(16):5669.

World Health Organization. How to investigate drug use in health facilities: selected drug use indicators. Geneva: World Health Organization; 1993. Available from: https://iris.who.int/server/api/core/bitstreams/83d355cb-89c2-4a43-8c1d-d6f07b56f365/content Accessed on 10 July 2026.

Mascarenhas D, Ho MSP, Ting J, Shah PS. Antimicrobial stewardship programs in neonates: a meta-analysis. Pediatrics. 2024;153(6):e2023065091.

McAleese S, Parikh TB, Ouddi B, Schumacher CM, Johnson J. Understanding variation in management of early-onset neonatal sepsis in India: a vignette-based survey. BMJ Paediatr Open. 2025;9(1):e003095.

WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. Oslo: Norwegian Institute of Public Health; 2025. Available from: https://atcddd.fhi.no/atc_ddd_index_and_guidelines/guidelines/ Accessed on 10 July 2026.

Ministry of Health and Family Welfare, Government of India. National list of essential medicines 2022. New Delhi: Ministry of Health and Family Welfare; 2022. Available from: https://www.cdsco.gov.in/opencms/opencms/en/consumer/Essential-Medicines/ Accessed on 10 July 2026.

Krzyżaniak N, Pawłowska I, Bajorek B. Review of drug utilization patterns in NICUs worldwide. J Clin Pharm Ther. 2016;41(6):612-20.

Alouzi N, Murabet F, Yamane M. Drug utilization study in the neonatal intensive care unit at Zawia Medical Center, Zawia, Libya. AlQalam J Med Appl Sci. 2026;9(3):622-7.

Kumari A, Prasad PL, Satyender. Drug utilization pattern in neonatal intensive care unit of a tertiary care hospital with particular emphasis on off-label drug use. J Clin Neonatol. 2019;8(1):15-8.

Chauthankar SA, Marathe PA, Potey AV, Nanavati RN. Drug utilization in neonatal intensive care unit of a tertiary-care hospital in Mumbai, India. Indian Pediatr. 2017;54(11):931-4.

Jayaram KB, Usha D, Bhushal P. Drug utilization pattern in a neonatal intensive care unit at tertiary care hospital attached to a medical college in Southern Karnataka, India. Int J Contemp Pediatr. 2019;6(3):978-82.

Chatterjee S, Mandal A, Lyle N, Mukherjee S, Singh AK. Drug utilization study in a neonatology unit of a tertiary care hospital in eastern India. Pharmacoepidemiol Drug Saf. 2007;16(10):1141-5.

Namdarifar F, Raouf S, Shahraki EM, Murthy NBS. Drug utilization study in neonatal intensive care unit at tertiary care hospital. Rev Assoc Med Bras (1992). 2022;68(2):212-6.

Shareef SM, Ahamed SM. Pattern of disease and drug use among neonates: results from a neonatal intensive care unit in a tertiary care hospital in South India. J Evid Based Med Healthc. 2019;6(20):1502-5.

Shanmugapriya DS, Sathyasuba RD, Sathyaprabha G, Kumar RS, Rajendran S, Marimuthu K, et al. Assessment of medication use patterns for managing neonatal sepsis at a tertiary care hospital. J Neonatal Surg. 2025;14(17S):460-5.

Kumar R, Zilate S, Naik C, Akhade K. Drug prescription trends in neonatal intensive care unit (NICU) at a tertiary care private teaching hospital in Central India. Int J Pharm Clin Res. 2023;15(9):274-7.

Kumbhar AV, Halasawadekar NR, Ramanand SJ, Ramanand JB, Patil PT, Shah RD, et al. Drug utilization study in a neonatal intensive care unit of a government tertiary care hospital in Western Maharashtra. Int J Basic Clin Pharmacol. 2018;7(8):1572-8.

Choure MK, Jadhav RR, Padwal SL. Drug utilization study in neonatal intensive care unit at rural tertiary care hospital. Asian J Pharm Clin Res. 2017;10(4):102-4.

Gandra S, Alvarez-Uria G, Murki S, Singh SK, Kanithi R, Jinka DR, et al. Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016. Int J Infect Dis. 2018;71:20-4.

Al-Turkait A, Szatkowski L, Choonara I, Ojha S. Drug utilisation in neonatal units in England and Wales: a national cohort study. Eur J Clin Pharmacol. 2022;78(4):669-77.

Gonçalves ACS, Reis AMM, Gusmão ACM, Bouzada MCF. Drug utilisation profile in the neonatal unit of a university hospital: a prospective observational study in Brazil. Int J Clin Pharm. 2015;37(4):645-55.

Krishnamoorthy Y, Govindan D, Karunakaran M, Parveen M, Manohar A, Al-Tawfiq JA. A systematic review of the effectiveness and cost-effectiveness of implementing antimicrobial stewardship program at tertiary care facilities in India. IJID Reg. 2025;15:100666.

Kommalur A, Baddadka V, Devadas S, Kariyappa M, Dakshayani B, Krishnapura Lakshminarayana S, et al. Decreasing antibiotic over-use by implementation of an antibiotic stewardship programme in preterm neonates in resource limited settings: a quality improvement initiative. Paediatr Int Child Health. 2021;41(2):103-11.

Abdelaal NH, Abdel Aziz NHR, Abdelaziz AM, Khalil SBH, Abdel-Latif MMM. Clinical impact of an antibiotic stewardship program in a neonatal intensive care unit at a tertiary care hospital: a prospective quasi-experimental clinical study. J Pharm Health Care Sci. 2025;11(1):81.

Runjhun, Agarwal N, Yadav A, Rao YK, Rao A. Optimising antibiotic use in the neonatal intensive care unit through implementation of antimicrobial stewardship program: a double cohort study. J Clin Diagn Res. 2025;19(11):SC06-9.

Hematian F, Aletayeb SMH, Dehdashtian M, Aramesh MR, Malakian A, Aletayeb MS. Frequency and types of antibiotic usage in a referral neonatal intensive care unit, based on the World Health Organization classification (AwaRe). BMC Pediatr. 2025;25(1):60.